ArticleResearch square2026
Body mass index decline and cognitive trajectories in mild cognitive impairment: the role of maternal history of Alzheimer's disease.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background: Maternal history of Alzheimer's disease (MH) has been associated with increased risk of Alzheimer's disease (AD), earlier onset, and distinct neurobiological features. In parallel, an anthropometric-metabolic phenotype characterized by body mass index (BMI) decline and unintentional weight loss has been described as an early feature preceding cognitive decline in the prodromal stages of AD. Objective: To investigate whether MH is associated with a distinctive anthropometric-metabolic and cognitive phenotype in individuals with mild cognitive impairment (MCI), focusing on longitudinal trajectories of body mass index (BMI), memory, and executive function. Methods: Participants with MCI from the Alzheimer's Disease Neuroimaging Initiative (ADNI) were analyzed over up to 24 months of follow-up. Longitudinal changes in BMI, memory, and executive function were examined using repeated-measures ANOVA. MH, APOE4 status, age, sex, and conversion to AD were included as between-subject factors. Results: Among 397 participants with MCI, 270 (68%) remained clinically stable and 127 (32%) converted to AD during follow-up. APOE4 positivity was more frequent among converters. BMI declined over time, with a steeper reduction observed in individuals who converted to AD and in those with MH. MH was associated with differential longitudinal cognitive trajectories, characterized by subtle non-linear changes in memory performance and relative preservation of executive function. Changes in BMI showed modest associations with memory and executive function trajectories. Conclusions: MH is associated with distinctive longitudinal patterns of anthropometric-metabolic and cognitive change in individuals with MCI. Incorporating maternal history may help refine phenotypic characterization in prodromal AD, supporting a more nuanced understanding of disease heterogeneity in the prodromal stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.